(marketscreener.com) Deep Genomics, the leading AI RNA therapeutics company, today announced that its Founder and CEO, Brendan Frey, PhD, FRSC, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 10:00 a.m. EST. The presentation will be available as a live webcast through the J.P. Morgan Healthcare Conference...https://www.marketscreener.com/news/latest/Deep-Genomics-to-Present-at-the-40th-Annual-J-P-Morgan-Healthcare-Conference--37482166/?utm_medium=RSS&utm_content=20220106
Deep Genomics is a Canada-based biopharmaceutical company that researches and develops AI-driven RNA therapeutics for the treatment of genetic conditions.